Johns Hopkins Antibiotic (ABX) Guide

Fosfomycin

INDICATIONS

FDA

NON-FDA APPROVED USES

FORMS[Top]

brand name

preparation

manufacturer

route

form

dosage^

cost*

Monurol

Fosfomycin

Forest

PO

pds

3 g

$46.25 per packet (3 grams)

*Prices represent cost per unit specified, are representative of "Average Wholesale Price" (AWP).
^Dosage is indicated in mg unless otherwise noted.

USUAL ADULT DOSING[Top]

  • Uncomplicated UTI: 3 gm sachet PO x 1 dose with or without food.
  • Complicated UTI: 3 gm sachet PO every 2-3 days (up to 21 days) on an empty stomach preferred.
  • Mix powder in 120 mL of cool water until it dissolves

RENAL DOSING[Top]

DOSING FOR GLOMERULAR FILTRATION OF 50-80

Usual dose.

DOSING FOR GLOMERULAR FILTRATION OF 10-50

No data, consider dose adjustment. 3gm x1 (uncomplicated UTI). Consider 3gm every 3 days for complicated UTI.

DOSING FOR GLOMERULAR FILTRATION OF <10 ML/MIN

No data, prolonged half-life consider dose adjustment or avoid due to decrease urinary excretion.

DOSING IN HEMODIALYSIS

Redose after dialysis, due to removal during HD.

DOSING IN PERITONEAL DIALYSIS

1 gram q 36 hours.

DOSING IN HEMOFILTRATION

CVVH: 77% removal during CVVH

ADVERSE DRUG REACTIONS[Top]

OCCASIONAL

  • GI intolerance: diarrhea (10%), nausea, and dyspepsia
  • Headache and dizziness
  • Vaginitis
  • Asthenia

RARE

DRUG INTERACTIONS[Top]

Antacids (calcium carbonate): reduction of fosfomycin absorption. Food decreases absorption of fosfomycin.

SPECTRUM[Top]

E. coli, enterococcus (including VRE), Pseudomonas, S. aureus (including MRSA) , Klebsiella spp., Proteus spp., Citrobacter spp., Enterobacter aerogenes, and Serratia marcescens. Relatively broad spectrum drug.

Spectrum of Activity

Pathogen

Line

Aerobic gram-negative bacilli

Proteus mirabilis

2nd line

Proteus vulgaris

2nd line

Klebsiella species

2nd line

Pseudomonas aeruginosa

2nd line

Escherichia coli

2nd line

Citrobacter species

2nd line

Enterobacter species

2nd line

Serratia species

2nd line

Aerobic gram-positive cocci

Staphylococcus aureus

2nd line

Enterococcus

2nd line

PHARMACOLOGY[Top]

MECHANISM

Fosfomycin interferes with bacterial wall synthesis by inhibiting the enzyme enolpyruvyl transferase (this enzyme catalyzes the formation of uridine diphosphate N-acetylmuramic acid which is the first step of bacterial cell wall synthesis).

PHARMACOKINETIC PARAMETERS

Absorption

30% absorbed with food; 37% absorbed without food.

Metabolism and Excretion

Converted to free acid fosfomycin. Excreted primarily in the urine. 18% excreted in the feces.

Protein Binding

No protein binding.

Cmax, Cmin, and AUC

64-128 mcg/ml; 3000 mcg/ml with a 3-g oral dose achieved in the urine.

T1/2

5.7 hrs

Distribution

Distributed into bladder wall, kidneys, prostate and seminal vesicles.

DOSING FOR DECREASED HEPATIC FUNCTION

No data, usual dose likely.

PREGNANCY RISK

B-Animal data shows no teratogenic effects. Several published reports studied the efficacy and safety of oral fosfomycin in all stages of pregnancy. In these studies fosfomycin did not cause harm to the fetus.

BREAST FEEDING COMPATIBILITY

No data, but expect excretion into breast milk due to low molecular weight of fosfomycin.

COMMENTS[Top]

Oral agent FDA approved only for uncomplicated UTI. Broad spectrum of activity includes all common uropathogenic bacteria. Single dose therapy (3 gram) was equivalent to 7-day course of norfloxacin in randomized, blinded study. May be used for VRE in UTIs if renal function is good. Due to limited systemic absorption, fosfomycin should not be used for severe pyelonephritis and urosepsis.

References[Top]

  1. Minassian MA et al: A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents 10:39, 1998   [PMID:9624542]

    Comment: Fosfomycin is a relatively expensive (AWP=$35/3gm sachet) alternative to TMP-SMX for the treatment of acute cystitis in women. An advantage is the single dose versus a 3 day treatment regimen

  2. Patel SS, Balfour JA, Bryson HM: Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53:637, 1997   [PMID:9098664]

    Comment: Comprehensive review of drug relative to treatment of UTI.

  3. Russell PJ et al: Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats. A model for intravesical radioimmunotherapy. Urol Res 19:207, 1991   [PMID:1926654]

    Comment: Single dose fosfomycin was equivalent to norfloxacin in females with uncomplicated UTI.

  4. Naber KG, Thyroff-Friesinger U: Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study. Infection 18 Suppl 2:S70, 1990   [PMID:2286465]

    Comment: Fosfomycin as single-dose therapy was compared with ofloxacin and trimethoprim-sulfamethoxazole, each also given as single-dose therapy; fosfomycin was significantly less effective in eradicating initial bacteriuria than was ofloxacin (135 [70%] of 194 vs. 92 [86%] of 107; P , .001). IDSA guidelines recommends fosfomycin as an alternative therapy for the treatment of uncomplicated urinary tract infection resistant to TMP/SMX.

  5. Bayrak O, Cimentepe E, Inegöl I, et al.; Is single-dose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy?; Int Urogynecol J Pelvic Floor Dysfunct.; Vol. 18; pp. 525-529; ISSN: 16941068;

    Comment: Fosfomycin x1 was as safe and effective as cefuroxime x 5d in 2nd trimester pregnant women with asymptomatic bacteriuria.

Fosfomycin is a sample topic found in Johns Hopkins Guides.

To find other Johns Hopkins Guides topics please log in or purchase a subscription.

Content Manager
Related Content
Capnocytophaga canimorsus
Citrobacter species
Enterobacter species
Nitrofurantoin
Escherichia coli
Bacterial Cystitis Acute Uncomplicated
Enterococcus

more ...